NKTR

Nektar Therapeutics

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$76.99

Market Cap

$1.56B

Beta

1.23

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-43.89%

EPS Growth (YoY)-16.93%

Revenue CAGR 3Y-15.66%

P/E Ratio0.0

PEG Ratio—

FCF Yield-13.35%

Debt / Equity1.66

Interest Coverage-5.0x

No credit card required

Already have an account? Sign in to view the full analysis for NKTR.